Clinical Trials Logo
  1. Home
  2. Immunity
  3. NCT03062995

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy — MAESTRO  

Immunity Clinical Trial

Official title:
A Randomised, Double-blind, Controlled, Parallel-group, Multi-country Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy

Clinical Trial Summary

With the rising prevalence of allergic diseases and the subsequent risk of developing other immune-related disorders, primary prevention of allergy has become a major priority. It is generally acknowledged that breastfeeding is one of the main pillars in allergy prevention. Infant formulas based on hydrolysed proteins have been developed to be used by infants at increased risk of developing allergy in case a mother is unable or chooses not to breastfeed her infant. The effect of hydrolysed formula in allergy prevention has been examined in many studies, from which it can be concluded that currently there is not sufficient evidence to support hydrolysed protein over intact protein for allergy risk reduction. Moreover, several clinical trials support the suggestion of supplementation of pre and/or probiotics for the reduction of eczema development, recognized by international authorities. The present study (MAESTRO) investigates the preventive effect of a hypoallergenic concept combining several nutritional approaches related to preventive strategies: partially hydrolysed protein formula supplemented with prebiotics and probiotics. The aim of the present study is to investigate the efficacy, growth and safety of this concept compared to standard (intact protein) infant formula on the development of allergic manifestations up to the age of 12 months in infants at increased risk of developing allergy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03062995
Study type Interventional
Source Nutricia Research
Contact
Status Withdrawn
Phase Phase 3
Start date June 2019
Completion date December 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02814617 - The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity Phase 2/Phase 3
Completed NCT02244372 - Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity N/A
Completed NCT00990002 - Investigation of A Children's Beverage Containing Different Probiotics N/A
Completed NCT00788021 - Protective Immunity Project 01 N/A
Completed NCT01736787 - Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity N/A
Recruiting NCT04579588 - Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Completed NCT04798677 - Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine N/A
Completed NCT05162820 - Impact of Solarplast® on Immunity in Active Smokers and Non-smokers N/A
Completed NCT01657656 - Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia N/A
Completed NCT05585021 - Clinical Study on the Effect of Probiotic Compound Powder on the Immunity Improvement of Preschool Children N/A
Recruiting NCT05117385 - The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune) N/A
Completed NCT05190237 - the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement. N/A
Completed NCT04647071 - Allium Extracts on the Incidence of Respiratory Infection Symptoms in Healthy Elderly Volunteers N/A
Completed NCT04031222 - Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes
Completed NCT04010331 - Efficacy and Safety of Nokyong Mixture Extract(CME-PI) on Promotion of Immunity N/A
Completed NCT03067714 - A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy Phase 3
Completed NCT04664309 - Understanding Immunity to the COVID-19 Vaccines
Withdrawn NCT06121362 - Effect of Protocatechuic Acid on Biochemical Markers of Immunity Status in Healthy Adults N/A
Recruiting NCT02166931 - BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition N/A
Recruiting NCT00645996 - The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants N/A